Clinical Trial

Biochemical Response and Clinical Outcomes in Patients With PBC

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a bidirectional cohort study. The investigators conduct a bidirectional cohort study utilizing a database in mainland China, continuously collecting demographics, clinical symptoms, and biochemical characteristics of diagnosed PBC patients. The study aims to analyze the association between varying post-treatment alkaline phosphatase (AKP) levels and complication-free survival rates, with the objective to develop and validate a predictive survival model.
Trial Details
NCT Number NCT07449793
Lead Sponsor RenJi Hospital
Conditions Primary Biliary Cholangitis (PBC), Primary Biliary Cholangitis
Enrollment 3,000 participants
Start Date 2026-02-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-04